You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Johnson and Johnson
Harvard Business School
Dow
Moodys

Last Updated: February 19, 2020

DrugPatentWatch Database Preview

OMEPRAZOLE AND SODIUM BICARBONATE Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

When do Omeprazole And Sodium Bicarbonate patents expire, and when can generic versions of Omeprazole And Sodium Bicarbonate launch?

Omeprazole And Sodium Bicarbonate is a drug marketed by Actavis Elizabeth, Ajanta Pharma Ltd, Aurolife Pharma Llc, Dr Reddys Labs Ltd, Par Pharm, Perrigo R And D, Sciegen Pharms Inc, and Zydus Pharms. and is included in thirteen NDAs.

The generic ingredient in OMEPRAZOLE AND SODIUM BICARBONATE is omeprazole; sodium bicarbonate. There are one hundred and thirty-one drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the omeprazole; sodium bicarbonate profile page.

Summary for OMEPRAZOLE AND SODIUM BICARBONATE
Drug patent expirations by year for OMEPRAZOLE AND SODIUM BICARBONATE
Recent Clinical Trials for OMEPRAZOLE AND SODIUM BICARBONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BioPharma Services, IncPhase 1
Food and Drug Administration (FDA)Phase 1
CTC Bio, Inc.Phase 1

See all OMEPRAZOLE AND SODIUM BICARBONATE clinical trials

US Patents and Regulatory Information for OMEPRAZOLE AND SODIUM BICARBONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 204137-001 Jul 15, 2016 OTC No No   Start Trial   Start Trial   Start Trial
Ajanta Pharma Ltd OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 205545-001 Jul 27, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 204068-001 Jul 15, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Aurolife Pharma Llc OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 204922-001 Aug 19, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Perrigo R And D OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate CAPSULE;ORAL 201361-001 Jul 15, 2016 OTC No No   Start Trial   Start Trial   Start Trial
Par Pharm OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 079182-001 Apr 19, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Moodys
Boehringer Ingelheim
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.